Product Information
LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.0573 per EA under NDC 59746033710. Its NADAC has been published 291 times since Jan 27, 2021.
FDA first approved this application on Sep 18, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the losartan potassium and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5; 50 mg/1; mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746033710
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA201845FDA Approved
9/18/2012
TE Code
AB
On Market Since
10/30/2012
Pharmacological Classes
Price Statistics
The NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB has been published 291 times since Jan 27, 2021, and over the history we have for it it has declined 65.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0573 per EA |
|---|---|
| All-time high | $0.1848 (Apr 13, 2022) |
| All-time low | $0.0573 (Aug 19, 2026) |
| 52-week high | $0.0797 |
| 52-week low | $0.0573 |
| Median price | $0.0972 |
| Average price | $0.1080 |
| Largest weekly change | -22.4% (Nov 20, 2024) |
| Weeks tracked | 291 |
| Tracking since | Jan 27, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.0573 per EA (NDC 59746033710), effective Aug 19, 2026.
How has the price of LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB has declined 65.1%. It has been tracked across 291 weekly CMS publications since Jan 27, 2021.
What are the highest and lowest recorded NADAC prices for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?
Since Jan 27, 2021, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB has ranged from a low of $0.0573 (Aug 19, 2026) to a high of $0.1848 (Apr 13, 2022), with a median of $0.0972 per EA.
Are there cheaper alternatives to LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?
LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB (NDC 59746033710) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.